ArticleFrontiers in medicine2025
Hepatic encephalopathy due to non-cirrhotic portal hypertension associated with non-alcoholic steatohepatitis and chronic hepatitis B: a Case Report.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report examines the diagnostic and therapeutic complexities presented by a patient with hepatic encephalopathy resulting from overlapping pathologies of non-alcoholic steatohepatitis (NASH), hepatitis B virus (HBV) infection, and non-cirrhotic portal hypertension (NCPH). Highlighting the intricate relationship among these conditions, this study delineates the distinct and overlapping clinical features, diagnostic challenges, and therapeutic approaches. The patient exhibited atypical symptoms typical of NASH but lacked clear signs of cirrhosis, complicating both the diagnostic process and the therapeutic management. The diagnostic journey involved a nuanced assessment using multimodal imaging techniques, which were crucial in distinguishing between hepatic encephalopathy caused by cirrhosis and that due to NCPH. Treatment strategies had to be carefully tailored to address the specific etiological factors and pathology of the conditions involved, with particular attention to managing metabolic disorders such as insulin resistance and abnormalities in lipid and glucose metabolism, frequently observed in both NASH and HBV. The case underscores the need for a comprehensive and individualized approach in managing complex hepatic conditions, especially when conventional diagnostic criteria and treatment protocols face limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.